Zollinger-Ellison syndrome epidemiology and demographics

Jump to navigation Jump to search

Zollinger-Ellison syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Zollinger-Ellison syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Zollinger-Ellison syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Zollinger-Ellison syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Zollinger-Ellison syndrome epidemiology and demographics

CDC on Zollinger-Ellison syndrome epidemiology and demographics

Zollinger-Ellison syndrome epidemiology and demographics in the news

Blogs on Zollinger-Ellison syndrome epidemiology and demographics

Directions to Hospitals Treating Zollinger-Ellison syndrome

Risk calculators and risk factors for Zollinger-Ellison syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

The incidence of gastrinoma, which can cause Zollinger-Ellison syndrome, is approximately 0.05-0.2 per 100,000 individuals worldwide. About 25 to 30 percent of gastrinomas are caused by multiple endocrine neoplasia type 1 (MEN1).

Epidemiology and Demographics

Incidence

  • The worldwide incidence of gastrinomas is about 5 to 30 cases per 100,000 individuals per year. With improved techniques for tumor detection, the annual incidence has increased. About 80% to 90% of these tumors arise in the gastrinoma triangle. [1]

Age

  • Zollinger-Ellison syndrome is a disease that tends to affect the middle-aged adult population (20-50 years of age).[2]

Gender

  • Males are more commonly affected with Zollinger-Ellison syndrome than females.[2]

Race

  • There is no racial predilection to Zollinger-Ellison syndrome

References

  1. Cingam S, Karanchi H. PMID 28722872. Missing or empty |title= (help)
  2. 2.0 2.1 Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT (2006). "Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature". Medicine (Baltimore). 85 (6): 295–330. doi:10.1097/01.md.0000236956.74128.76. PMID 17108778.

Template:WH Template:WS